###### Article summary

Article focus
=============

-   Community-associated methicillin-resistant *Staphylococcus aureus* (CA-MRSA) is common among men who have sex with men (MSM) in the USA.

-   It is unknown whether this is also the case in Amsterdam, the Netherlands.

-   In a cross-sectional study at the sexually transmitted infection (STI) outpatient low-threshold clinic, Amsterdam, the Netherlands, we studied the prevalence of *S aureus* and MRSA colonisation and infections among symptomatic and asymptomatic MSM.

Key messages
============

-   Among MSM visiting the STI clinic in Amsterdam CA-MRSA is rare.

-   Genital colonisation of *S aureus* is not associated with high-risk sexual behaviour.

Strengths and limitations of this study
=======================================

-   The conclusions are based on systematically collected and aggregated data. The study was limited to the Amsterdam MSM population visiting the STI outpatient clinic.

Introduction {#s1}
============

*Staphylococcus aureus* is a pathogen that can cause skin and soft tissue infections. Nasal carriage plays an important role in the epidemiology and pathogenesis of this infection.[@R1] [@R2] Around 20% (range 12--30%) of individuals are persistent *S aureus* nasal carriers, approximately 30% (range 16--70%) are intermittent carriers and about 50% (range 16--69%) are non-carriers.[@R1] [@R3] A causal relation between *S aureus* nasal carriage and infection is supported by the fact that often the nasal *S aureus* strain and the infecting strain are the same phage type or genotype.[@R4] Local antibiotic treatment of *S aureus* from the nares results in the subsequent disappearance of *S aureus* from other parts of the body.[@R1] [@R2] [@R4; @R5; @R6] Extranasal sites that typically harbour the organism include the skin, perineum and pharynx.[@R7] [@R8]

Most strains of *S aureus* are methicillin-susceptible *S aureus* (MSSA), but some strains, called methicillin-resistant *S aureus* (MRSA), are resistant to methicillin and all β-lactam antibiotics with the exception of the novel cephalosporin, ceftaroline, that can bind to penicillin-binding protein (PBP2a). MRSA has become a major nosocomial infection control problem (known as healthcare-associated MRSA, or HA-MRSA) in many parts of the world[@R9] with the exception of the Netherlands and of Scandinavian countries.[@R10] [@R11] Later on, independent from healthcare institutions, MRSA emerged outside healthcare institutions, like the community-associated (CA-MRSA)[@R12] [@R13] and livestock-associated (LA-MRSA) infections.[@R14] [@R15] Resistance to methicillin and other β-lactams in *S aureus* is based on an additional PBP which is coded by a mec gene such as mecA.[@R8] Homologues of mecA such as mecC were described recently.[@R15]

CA-MRSA is distinguished from HA-MRSA by clinical, laboratory and epidemiological characteristics.[@R16] A new CA-MRSA clone (USA300) has been described and was identified in several communities in the USA and Canada.[@R17; @R18; @R19] New clones of CA-MRSA have also been reported in Europe.[@R15] [@R17] CA-MRSA often produces Panton-Valentine leukocidin (PVL), a toxin that causes polymorphonuclear leucocyte lysis and tissue necrosis.[@R17] [@R18]

In men who have sex with men (MSM), outbreaks of CA-MRSA skin infections have been reported and the majority of the patients were HIV infected.[@R8] [@R19; @R20; @R21; @R22] It has been suggested that CA-MRSA might be transmitted in this population from skin to skin during sexual contact.[@R21] [@R22]

A cross-sectional study among 104 men conducted in Italy did not detect a single case of colonisation with CA-MRSA in HIV-infected MSM.[@R23] No other study in Europe has reported the prevalence of CA-MRSA colonisation in MSM. The purpose of this investigation was to evaluate the prevalence of, and sexual risk factors for *S aureus* colonisation (MSSA and MRSA) and CA-MRSA infection among MSM visiting the sexually transmitted infection (STI) outpatient clinic in Amsterdam.

Methods {#s2}
=======

Study population {#s2a}
----------------

Consecutive MSM attending the STI outpatient clinic in Amsterdam, the Netherlands, were invited to participate in this cross-sectional study. We aimed to include both symptomatic men (those who had clinical signs of a skin or soft tissue infection (pustules, abscesses, ulcerations, erythematous painful papules or plaques)) and asymptomatic men (those without aforementioned clinical signs). All participants were asked to complete a questionnaire concerning hospital admissions during the past year, factors known to be associated with *S aureus* colonisation (eg, sharing razor blades and tending animals), STI risk factors and sexual behaviour. STI risk factors were also obtained from the electronic files of the routine patient history.

Swabs were taken from the anterior nasal cavity, throat, perianal area and penile glans. From symptomatic men swabs from suspected infected skin lesions were also obtained. If MRSA was detected, the participant was referred to his general practitioner for an eradication therapy, and the sexual partners of the patient were invited for MRSA screening. The study was approved by the ethics committee of the Academic Medical Center of the University of Amsterdam. All participants provided written informed consent.

Laboratory tests {#s2b}
----------------

Culture for *S aureus* was carried out on blood agar plates and for MRSA on selective chromagar plates after enrichment in broth. *S aureus* strains were confirmed by the SA442 (Martineau) nucleic acid amplification test (NAAT) and MRSA strains by the mecA NAAT.[@R24] [@R25] If MRSA was found, the spa-gene was sequenced as described before.[@R26]

Statistical analysis {#s2c}
--------------------

A sample size calculation was carried out prior to the study. The prevalence of MRSA carriage in the general population was estimated to be 0.03%.[@R24] We aimed to assess whether the MRSA prevalence among MSM patients of the STI clinic was at least 3%. To reject the null hypothesis (prevalence of 0.03% or less among the studied group) with a study power of 95% and a significance level of 0.05, a sample size of at least 113 asymptomatic men was needed; this was rounded up to 125. As men with signs suggestive of *S aureus* skin or soft tissue infection were thought to be more likely to be infected with MRSA, we also aimed to include a group of 75 symptomatic men. Because the expected number of asymptomatic men was much larger than that of symptomatic patients, the inclusion period for the symptomatic participants was scheduled to be longer.

The electronic patient file with routine STI screening data, the questionnaire and the laboratory results were merged into one database. The χ^2^ test or Fisher\'s exact test were used to compare categorical variables between groups; the rank sum test was used to compare continuous variables between groups. Data analyses were performed with STATA software (STATA Intercooled, College Station, Texas, USA), V.11.0. p Values of less than 0.05 were considered statistically significant. Associations between possible risk factors and anogenital *S aureus* colonisation were examined with multivariable logistic regressions, reporting adjusted OR with 95% CI. An initial model included all variables that were significant in bivariable analyses; variables were dropped one by one from the model based on the likelihood ratio test (if p\>0.05); HIV was forced into the model.

Results {#s3}
=======

In total 214 men were included, starting November 2008. The inclusion of asymptomatic men was completed in December 2008 and of symptomatic men in April 2010. From three participants laboratory results were not available and these were excluded, leaving 211 MSM for the analysis (137 asymptomatic and 74 symptomatic participants). The median age of men in the two groups was similar (38 and 41 years, respectively, p=0.32, see [table 1](#BMJOPEN2012002505TB1){ref-type="table"}). Men in the two groups were comparable regarding most non-sexual risk factors, sexual risk factors and STI diagnoses, but symptomatic men were more often found to be HIV infected (53% vs 31%; p=0.002) and were more often diagnosed with syphilis (12% vs 1%; p\<0.001). Also, use of some drugs (cannabis, cocaine and methamphetamine) was significantly more common in the symptomatic group.

###### 

Demographic, behavioural and clinical characteristics, and *S aureus* colonisation of five anatomical locations, of 211 MSM attending the STI clinic, Amsterdam, 2008--1010, according to symptomatology of skin or soft tissue infection

                                        Asymptomatic   Symptomatic   p Value          
  ------------------------------------- -------------- ------------- --------- ------ ---------
  \(A\) Demographics                                                                  
   Median age in years (IQR)            38 (31--45)    41 (31--48)   0.32             
   Dutch ethnicity                      111            81.0          54        73.0   0.18
  \(B\) Recreational drugs use                                                        
   None                                 21             15.3          7         9.5    0.23
   Alcohol                              92             67.2          47        63.5   0.60
   Cannabis                             34             24.8          33        44.6   0.003
   XTC                                  40             29.2          27        36.5   0.28
   GHB                                  36             26.3          25        33.8   0.25
   Poppers (alkyl nitrites)             76             55.5          44        59.5   0.58
   Cocaine                              29             21.2          27        36.5   0.02
   Ketamine                             14             10.2          13        17.6   0.13
   Amphetamine                          8              5.8           7         9.5    0.33
   Methamphetamine                      3              2.2           6         8.1    0.04
  \(C\) Sexual history                                                                
   Number of sexual partners\*                                                        0.77
    0                                   19             13.8          9         12.2   
    1--4                                30             21.9          14        18.9   
    5--9                                20             14.6          11        14.9   
    10--19                              28             20.4          15        20.3   
    20--39                              26             19.0          12        16.2   
    40 or more                          14             10.2          13        17.6   
   Active anal sex with condom†         98             71.5          48        64.9   0.32
   Passive anal sex with condom†        79             57.7          58        78.4   0.003
   Active anal sex without condom†      68             49.6          32        43.2   0.38
   Passive anal sex without condom†     56             40.9          37        50.0   0.20
   Active fisting†                      21             15.3          15        20.3   0.36
   Passive fisting†                     14             10.2          11        14.9   0.32
   Had group sex\*                      60             43.8          38        51.4   0.29
   Visited a sex club\*                 85             62.0          47        63.5   0.83
   Visited a sex party\*                31             22.6          17        23.0   0.95
   Met sex partner through internet\*   75             54.7          45        60.8   0.40
   Had sex abroad\*                     79             57.7          45        60.8   0.66
  \(D\) STI: history and diagnoses                                                    
   History of STI                       34             24.8          24        32.4   0.24
   HIV infected‡                        42             30.9          38        52.8   0.002
   Syphilis diagnosis                   1              0.7           9         12.2   \<0.001
   Gonorrhoea diagnosis                 9              6.6           5         5.4    0.74
   Chlamydia diagnosis                  23             16.8          14        18.9   0.70
  \(E\) *S aureus* colonisation                                                       
   Nares                                50             36.5          28        37.8   0.85
   Pharynx                              13             9.5           10        13.5   0.37
   Perineum                             9              6.6           17        23.3   \<0.001
   Glans penis                          10             7.3           12        6.2    0.043
   Other locations§                     ----           ----          27        40.3   ---

\*During the previous year.

†In the past 6 months.

‡HIV status missing for three patients who did not want to be tested.

§Data available from 67/74 only.

GHB, γ-hydroxybutyric acid; MSM: men who have sex with men; *S aureus*, *Staphylococcus aureus*; STI, sexually transmitted infection; XTC, MDMA/methamphetamine.

The prevalence of *S aureus* colonisation (including MSSA and MRSA) was 37% (78/211) in the nose, 11% (23/211) in the throat, 12% (26/210) in the perineum and 10% (22/211) on the glans penis. The prevalences were similar between symptomatic and asymptomatic men for nose and throat, but the symptomatic group had significantly higher penile and perineal colonisation prevalences ([table 1](#BMJOPEN2012002505TB1){ref-type="table"}). In the symptomatic group 40% (27/67) of men had an *S aureus*-infected skin lesion. In one symptomatic and one asymptomatic case MRSA was detected, giving an overall prevalence of MRSA carriage of 0.9% (95% binomial exact CI (95% CI) 0.1% to 3.4%), and a prevalence of 0.7% (95% CI 0.02% to 4.0%) among asymptomatic MSM. Details of these two cases are described in the following. Neither known CA-MRSA nor PVL toxin-producing clones were detected.

*S aureus* colonisation of the anogenital area (based on penile and perianal swabs) was found in 18% (38/211) of the participants. Participants with and without anogenital *S aureus* colonisation were similar in respect to sexual risk behaviour, drug use, history or diagnosis of sexually transmitted diseases, antibiotic exposure, circumcision status and hygiene behaviour, but men with anogenital *S aureus* colonisation were older (42 vs 38 years; p=0.05), and they were more often HIV infected (58% vs 34%, p=0.007; see [table 2](#BMJOPEN2012002505TB2){ref-type="table"}). In a multivariable logistic regression analysis, adjusting for age, HIV status (adjusted OR, aOR 2.2, 95% CI 0.96 to 4.9), belonging to the symptomatic group (aOR=2.7, 95% CI 1.2 to 5.9) and having had few sexual partners (aOR 3.1, 95% CI 1.2 to 8.3 for those with \<5 sexual partners in the previous year compared to those with over 20 sexual partners) were independently and significantly associated with anogenital *S aureus* colonisation.

###### 

Demographic, behavioural and clinical characteristics of 211 MSM attending the STI clinic in Amsterdam, 2008--10, by *S aureus* anogenital colonisation status

                                        *S aureus* negative   *S aureus* positive   p Value          
  ------------------------------------- --------------------- --------------------- --------- ------ -------
  \(A\) Demographics                                                                                 
   Median age in years (IQR)            38 (30--45)           42 (35--49)           0.05             
   Dutch ethnicity                      138                   79.8                  27        71.1   0.24
  \(B\) Recreational drug use                                                                        
   None                                 21                    12.1                  7         18.4   0.30
   Alcohol                              118                   68.2                  21        55.3   0.13
   Cannabis                             57                    33.0                  10        26.3   0.43
   XTC                                  53                    30.6                  14        36.8   0.46
   GHB                                  49                    28.3                  12        31.6   0.69
   Poppers                              96                    55.5                  24        63.2   0.39
   Cocaine                              44                    25.4                  12        31.6   0.44
   Ketamine                             23                    13.3                  4         10.5   0.64
   Amphetamine                          12                    6.9                   3         7.9    0.84
   Methamphetamine                      7                     4.1                   2         5.3    0.74
  \(C\) Sexual history                                                                               
   Number of sexual partners\*                                                                       0.08
    0                                   18                    10.4                  10        26.3   
    1--4                                35                    20.2                  9         23.7   
    5--9                                29                    16.8                  2         5.3    
    10--19                              35                    20.2                  8         21.1   
    20--39                              33                    19.1                  5         13.2   
    40 or more                          23                    13.3                  4         10.5   
   Active anal sex with condom†         121                   69.9                  25        65.8   0.62
   Passive anal sex with condom†        110                   63.6                  27        71.1   0.38
   Active anal sex without condom†      85                    49.1                  15        39.5   0.28
   Passive anal sex without condom†     74                    42.8                  19        50.0   0.42
   Active fisting†                      29                    16.8                  7         18.4   0.81
   Passive fisting†                     22                    12.7                  3         7.9    0.41
   Had group sex\*                      80                    46.2                  18        47.4   0.90
   Visited a sex club\*                 109                   63.0                  23        60.5   0.78
   Visited a sex party\*                36                    20.8                  12        31.6   0.15
   Met sex partner through internet\*   102                   59.0                  18        47.4   0.19
   Had sex abroad\*                     105                   60.7                  19        50.0   0.23
  \(D\) STI: history and diagnoses                                                                   
   History of STI                       51                    29.5                  7         18.4   0.17
   HIV infected‡                        59                    34.3                  21        58.3   0.007
   Syphilis diagnosis                   10                    5.8                   0         0      0.13
   Gonorrhoea diagnosis                 13                    7.5                   0         0      0.08
   Chlamydia diagnosis                  30                    17.3                  7         18.4   0.87
  \(E\) Other possible risk factors                                                                  
   Regularly attends the gym\*          109                   63.0                  20        52.6   0.24
   Regularly plays in a team sport\*    13                    7.5                   0         0      0.08
   Regularly visits the sauna\*         110                   63.6                  23        60.5   0.72
   Regularly takes a public shower\*    103                   59.5                  25        65.8   0.48
   Regularly travels abroad\*           149                   86.1                  32        84.2   0.76
   Regularly shaves                                                                                  
    Facial hair                         165                   95.4                  38        100    0.18
    Pubic hair                          149                   86.1                  31        81.6   0.47
    Body hair                           110                   63.6                  20        52.6   0.21
   Has pets                             45                    26.0                  11        29.0   0.71
   Works in healthcare                  14                    8.1                   3         7.9    0.97
   Was admitted to hospital\*           9                     5.2                   4         10.5   0.22
   Had surgery\*                        23                    13.5                  8         21.6   0.21
   Had a blood transfusion\*            6                     3.5                   1         2.6    0.79
   Had enemas\*                         49                    28.3                  14        36.8   0.30
   Frequently bites his fingernails     55                    31.8                  11        29.0   0.73
   Has been circumcised                 36                    20.8                  11        29.0   0.28

\*During the previous year.

†In the past 6 months.

‡\*HIV status missing for three patients who did not want to be tested.

GHB, γ-hydroxybutyric acid; MSM: men who have sex with men; *S aureus*, *Staphylococcus aureus*; STI, sexually transmitted infection; XTC, MDMA/methamphetamine.

We examined associations between nasal carriage of *S aureus* and a long list of possible non-sexual risk factors, like admissions, operations, employment in healthcare sector, shaving habits, participation in team sports, sauna visits and other factors; none of these was associated with *S aureus* colonisation of the nose.

Asymptomatic carrier of MRSA {#s3a}
----------------------------

An HIV-infected 40-year-old, asymptomatic, Dutch MSM was positive for MRSA at the perineum. The MRSA had spa-type t064 and was resistant to ciprofloxacin, gentamicin, oxacillin, penicillin and trimethoprim/sulfamethoxazole. Further genetic analysis revealed mecA+ and Martineau+; pUSA03 and PVL were both negative. Recently, the patient was diagnosed with a hepatitis C infection. In the preceding year he had been hospitalised for an elective operation. He had travelled abroad frequently, including to the USA. He regularly used recreational drugs and visited a public gym and sauna. Furthermore, he engaged in high-risk sex, including unprotected anal intercourse, active and passive fisting, group sex, sex at sex parties and sex with partners met through the internet. We attempted to trace six of his sexual partners of whom four were screened. None had MRSA and none had clinical signs of a skin infection.

Symptomatic carrier of MRSA {#s3b}
---------------------------

In an HIV-infected, 46-year-old Dutch MSM, MRSA was detected on swabs taken from a penile ulcer, the nasal cavity, the perineum and the glans penis. The MRSA had spa-type t002 and was resistant to ciprofloxacin, erythromycin, oxacillin and penicillin. Further genetic analysis revealed mecA+ and Martineau+; pUSA03 and PVL were both negative. In the preceding year the patient had neither been hospitalised, nor operated upon, nor had he travelled abroad. He did not use recreational drugs, and did not visit public gyms or saunas. He had not engaged in high-risk sex; he had had sex with one partner in the preceding year. This partner could not be traced for further screening.

Discussion {#s4}
==========

The prevalence of MRSA among MSM clients of the STI outpatient clinic in Amsterdam was 0.9% (95% CI 0.1% to 3.4%); among clients without skin lesions this was 0.7% (95% CI 0.02% to 4.0%). This is similar to the overall prevalence in Dutch hospitals (1.8%).[@R11] No CA-MRSA-associated clones were found in this population. These findings are in contrast to reports from the USA where considerable CA-MRSA prevalences were observed among MSM attending STI screening sites.[@R21] [@R27] Although some MSM residing in Amsterdam frequently travel to the North American continent, this has not resulted in an extensive introduction of CA-MRSA within the Amsterdam population yet. The low MRSA prevalence among the Dutch population in general and among the MSM STI clinic population may be attributed to the strict Dutch search-and-destroy policy and restrictive antibiotic prescription policy.[@R10] At present, there is no indication for routine screening of MSM STI clinic visitors for CA-MRSA in the Netherlands.

We observed similar prevalences of *S aureus* nasal colonisation (37%) in MSM as observed in the general population.[@R1] Genital *S aureus* colonisation was associated with HIV infection; although HIV infection may be considered a proxy for high-risk sexual behaviour, other markers for risk behaviour were not significantly associated with *S aureus* colonisation. We attribute the more common colonisation among HIV-positive participants to their immunocompromised status. Unfortunately, we neither have data on virological, immunological or clinical parameters of HIV infection, nor about use of antiretroviral drugs. We did not observe an increased risk of *S aureus* nasal carriage among HIV infected, as was reported earlier.[@R28]

In contrast to Southern European countries, the Netherlands has a low rate of HA-MRSA, probably owing to the aforementioned search-and-destroy policy. The restricted use of β-lactam antibiotics outside of hospitals, in the community, might explain the low prevalence of CA-MRSA. Europe has not yet been confronted with CA-MRSA on a wide scale[@R23] contrary to Canada and the USA where high prevalences are found.[@R9] [@R12] [@R13] [@R21; @R22; @R23] Yet, in contrast to low prevalences of HA-MRSA and CA-MRSA in the Netherlands, screening of Dutch workers with livestock has revealed that 39% of slaughterhouse pigs and \>20% of pig farmers are asymptomatic carriers of LA-MRSA belonging to sequence-type (ST) 398.[@R14] The two MRSA strains isolated in our study were both unrelated to this LA-MRSA epidemic.

In conclusion, CA-MRSA among MSM visiting the STI outpatient clinic in Amsterdam is rare. Although genital *S aureus* colonisation was more common among HIV-infected MSM, we found no association between high-risk sexual behaviour and genital colonisation with *S aureus*. In the Netherlands there is no indication for MRSA screening of MSM attending STI clinics.
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